PET THERAPY

Volunteers and their dogs are available to visit patients various times during the week. If you're a patient in the hospital, feel free to request a visit from the Buddy Brigade.

FINDING HER STRIDE

On April 7, Tanya Waring-Hearn joined thousands of others for the 41st Cooper River Bridge Run. It was the first time she’s done it. Ironically, it took a diagnosis of cancer to get her there.
 Tanya celebrates her first bridge run

RULING OUT LUNG CANCER

A new biomarker is 98 percent effective at distinguishing benign from malignant lung tumors.
 Blood test rules out lung cancer

CLINICAL TRIAL

Results from a recent clinical trial to treat lung cancer show that a novel immunotherapy combination is surprisingly effective at controlling the disease’s progression.
 New drug combination advances treatment

HCC FELLOWSHIP PROGRAM

The inaugural fellowship program support promising trainees who are working on a spectrum of cancer-related projects
 Hollings announces Fellowship awardees

SURVIVOR SHARES WARNING

With colon cancer striking younger ages, survivor Courtney Nelson, shares a warning with others.
 A young mother’s battle against colon cancer

Hollings Cancer Center

A National Cancer Institute Designated Cancer Center

Doctors & Researchers

Doctors & Researchers

Behind every patient stands a multidisciplinary team of cancer specialists who work together to determine the best care plan for each patient, and across our campus leading scientists and researchers work daily to unlock the clues to cancer.

In the Headlines

Mark Rubinstein, Ph.D., and John Wrangle

Hollings Cancer researchers publish results, in The Lancet Oncology about a novel immunotherapy combination that shows promise for lung cancer patients.

More Headlines

Upcoming Events

HCC Special Events

The 3rd Annual Linda Floyd Forum on Women's Cancers is complimentary event to share, learn and engage in dialogue with experts from the Hollings Cancer Center.

ABOUT HOLLINGS

Why Hollings?

Why Hollings - Physician hugging patient

This year, more breakthroughs will be discovered. More cancer patients will find hope. And Hollings Cancer Center will be on the leading edge of offering better options to patients. As a cancer center that combines patient care and research, Hollings brings together over 180 physicians and scientists who are driving the discoveries that will lead to tomorrow’s treatments.


Quality & Awards

National Cancer Institute Designation

The only National Cancer Institute-Designated Cancer Center in South Carolina, Hollings is at the forefront of cancer research. This research is the driving force behind delivering medical advances to patients and their families, enabling us to educate health care professionals and the public, and to establish outreach services for underserved populations.

Learn more about NCI Designation

"We are so fortunate to have a cancer center offering groundbreaking research and top-notch patient care right here in South Carolina"

- Senator Ernest "Fritz" Hollings

Health Focus: SC Public Radio

Bobbi Conner talks with Dr. Sharlene Wedin about coping with chronic illness.

 Coping with Chronic Illness

Hollings in the Community

Give to Hollings

Upcoming Event
Cancer Immunology Research
Program Seminar

April 27, 2018

12:00 p.m. to 1:00 p.m. | HCC 120

Kai Wucherpfennig, M.D., Ph.D.
Professor of Microbiology & Immunobiology,
Harvard Medical School Chair & Professor; Department of Cancer Immunology & Virology, Dana-Farber Cancer Institute

"Resistance to Cancer Immunotherapy”

Follow Us on Twitter

PATIENT CARE

Patient Care at Hollings

Patient Care at Hollings

As one of the leading cancer treatment centers in the Southeast, Hollings Cancer Center combines the full range of cancer specialties to deliver a higher level of care to the patients we serve. Our team of more than 60 sub-specialists – each concentrating on a specific discipline of cancer treatment and care – works with individual patients to develop customized treatment programs that target a broad range of conditions. Our specialists work together as a team, often meeting with patients under the same roof on the same day. We are striving to deliver the highest level of care in the best way possible.

Find a Cancer Care Location

The heart of our patient care is located in downtown Charleston, SC. Patients may also be seen in oncology clinic locations closer to home.

Hollings arial view

Patient Stories

Patient Stories

Personalized patient care is at the center of everything we do. And no one tells the story better than our patients themselves. Meet some of our patients and hear about their cancer journey.

Patient Stories

Refer a Patient

Refer a Patient

Patients may be referred to Hollings by calling MEDULINE at 843-792-2200 or 800-922-5250, MUSC’s dedicated consultation line open 24/7 exclusively for health care professionals or through the online Patient Referral Portal.

Find a Nurse Navigator

Patient Resources

Patient & Family Resources

Hollings offers resources for patients, families and those interested in learning more about cancer prevention and risk. These include our Patient & Family Resource Room, the online MUSC Health Library and many services and support networks.

Patient Resources

Clinical Trials

Is a clinical trial right for you?

Every treatment that has ever made a difference in cancer was once a part of a clinical trial. The Hollings Cancer Center is committed to offering the best treatments available today while searching for even better ones for the future.

Find a Clinical Trial

As an NCI-Designated Cancer Center, Hollings Cancer Center is part of a national network of clinical trials, with access to hundreds of trials across the United States.

RESEARCH

Making a Difference through Cancer Research

Doctor

Hollings Cancer Center is home to more than 120 scientists conducting research and collaborating on better ways to prevent, detect, diagnose and treat this complex disease. As one of 69 National Cancer Institute-Designated Cancer Centers, Hollings continues to attract top cancer researchers from leading institutions across the country who are conducting research in the community, laboratory and clinic.

Research Programs

  • Cancer Biology
    • The scientific goal of the Cancer Biology Program is to identify novel genomic and genetic alterations that play causal roles in cancer development and to study genes, proteins, and signaling pathways that mediate the altered phenotypes of cancer cells.

  • Cancer Immunology
    • The scientific goal of the Cancer Immunology Program is to understand the basic mechanisms by which the immune system is regulated in cancer and to apply these discoveries to the development of immunotherapy trials.

  • Developmental Cancer Therapeutics
    • The scientific goal of the Developmental Cancer Therapeutics Program is to discover and characterize unique agents and pathways that will impact the development of more effective cancer therapies and to translate these discoveries into clinical applications by using proof-of-principle, early phase clinical and correlative science studies.

  • Cancer Control
    • The scientific goal of the Cancer Control Program is to foster population-based research that will lead to a reduction in cancer morbidity and mortality in South Carolina while providing scientific evidence and novel cancer control interventions that can be applied beyond the state’s borders.

HCC Fellowship Program

The HCC Fellowship Program is currently accepting applications for Postdoctoral/Clinical Fellows and Graduate Fellows. The program is designed to train the next generation of exceptional cancer scientists in the fields of basic, translational, population or clinical sciences.

HCC Fellowship Program
Back to top Back to top